Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus (Q79379327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

1 reference

Jeffrey W Stephens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Steven J Hurel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gordon D O Lowe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Ann Rumley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Steve E Humphries

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

22 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

422-428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

The pathophysiologic roles of interleukin-6 in human disease

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Interleukin-6 and the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Interleukin-6 g.−174G>C Promoter Polymorphism Is Associated with Obesity in the EPIC-Potsdam Study*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

The molecular genetics of cardiovascular disease: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.004

10.1016/J.YMGME.2006.10.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123852%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference